XPC-7224

N/A

Report date: 2025/01/26 17:21:04
NME

Base Information

Drug NameXPC-7224
Drug Alias Nameselective Nav1.6 inhibitor (Xenon Pharmaceuticals)XPC-7224
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type VIII alpha subunit blockers
TargetsSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesXenon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A